About
Six patients experienced biochemical recurrence, all of whom had intermediate- or high-risk prostate cancer. There is also a dearth of data evaluating the safety of testosterone therapy in men treated with radiation therapy (RT). However, the saturation model introduced by Morgentaler is based on the concept that prostate cancer cells' response to the testosterone level to which they are exposed is not linear in nature. Studies were ineligible if they used supra-physiologic levels of testosterone or if participants were using androgens other than testosterone. The other men in the study already had metastatic disease at the time of testosterone initiation.Keeping those caveats in mind, in one study (2) of healthy adult males between the ages of 40 and 70, researchers observed these normal total testosterone levels. In a 12-week study in 82 men, 72.6% of patients achieved a total testosterone concentration within the physiological range at steady state.434 Men treated with the agent were compared to a group of patients given 5 mg of a testosterone gel formulation, and no differences in mean testosterone serum levels were observed between the two groups.435 The study showed 92% of buccal versus 83% of gel patients achieved testosterone levels in the physiologic range. The main purpose of testosterone therapy is to return patients to normal physiological testosterone levels and provide relief of symptoms or signs. PSA secretion is an androgen dependent phenomenon, and the rise of PSA levels in patients on testosterone therapy is primarily dependent upon baseline total testosterone levels. It is the opinion of this Panel that serum PSA levels should be measured prior to the commencement of testosterone therapy in patients over 40 years of age in order to minimize the risk of prescribing testosterone therapy to men with occult prostate cancer. At the end of the study, serum testosterone levels rose in those men receiving testosterone therapy; however, no rise in testosterone levels were seen within the prostate tissue itself. Patients with testosterone deficiency who maintain testosterone levels in the normal range while on testosterone therapy should have their PSA levels tested, utilizing a shared decision-making approach, in accordance with the AUA's Early Detection of Prostate Cancer Guideline.
Currently published studies have not demonstrated an increased risk of biochemical cancer recurrence in post-RP patients who are on testosterone therapy, nor does it define the optimal timing for commencement of testosterone therapy. Included studies had significant heterogeneity with the populations themselves, methods of assessment, study durations, baseline population characteristics, and number of participants, leading the Panel to conclude that there is currently insufficient evidence to determine if testosterone therapy impacts QoL in a meaningful way. Despite the absence of definitive evidence, the Panel recommends that patients with these symptoms be counseled regarding the possibility of improvement on testosterone therapy.
The climbers then took 8 days to return to Kathmandu, where their blood was examined for a second time. During this period they were about 6,000 metres above sea level. StudyThe Italians wanted to find out more about the effect of high altitude on male fertility and hormone balance. This treatment is not appropriate for all men and requires thorough medical evaluation.
Randomized controlled trials (RCTs) were sought for effectiveness questions, whereas both randomized and non-randomized studies were sought for adverse events and questions of association and risk factors. Minimal data were found regarding outcomes of frailty, risk of venous thromboembolism, hyperestrogenemia, sleep apnea, prostate biopsy, recurrence of treated prostate cancer, and incidence of breast cancer. To be scientifically accurate, the Panel chose the term testosterone deficiency. Clinicians may use aromatase inhibitors, human chorionic gonadotropin, selective estrogen receptor modulators, or a combination thereof in men with testosterone deficiency desiring to maintain fertility. Testosterone therapy should not be commenced for a period of three to six months in patients with a history of a cardiovascular events. The long-term impact of exogenous testosterone on spermatogenesis should be discussed with patients who are interested in future fertility. Patients with persistently high prolactin levels of unknown etiology should undergo evaluation for endocrine disorders.
The long-term adaptations as shown in saliva and urine probably reflect free testosterone and adaptations involving sex-hormone binding globulin. When high-altitude-living men and low-altitude-living men in Peru had their urinary testosterone compared, it started out at a similar level, but the sea level subjects had much greater response to injections of hCG. Resting time could have been anywhere from sea level to 1200 meters (4000 feet).
The controversy surrounding prostate cancer and testosterone stems from the work of Dr. Charles Huggins who discovered that treating metastatic prostate cancer patients with ADT resulted in cancer remission,341 suggesting that the presence of testosterone would lead to an increased likelihood of prostate cancer development. Men were eligible for inclusion in the study if they had testosterone in the normal range, an unremarkable reproductive history and physical exam, and 2 semen samples with a sperm concentration of ≥20 million/mL. When only RCTs of men with baseline total testosterone values 326 It is unlikely that these changes represent clinically meaningful differences. A similar meta-analysis of only RCTs demonstrated no changes in total cholesterol or triglycerides in men who were on testosterone as compared to those on placebo. Several meta-analyses have evaluated the impact of testosterone therapy on lipid profiles. Other meta-analyses that have included observational studies with less stringent inclusion criteria have demonstrated variable improvements in fasting glucose, insulin resistance, and HbA1c levels.138, 325, 326